AMENDED AND RESTATED SUB-PLACEMENT AGENT AGREEMENTSub-Placement Agent Agreement • April 27th, 2018 • BlackRock Health Sciences Trust • New York
From time to time BlackRock Investments, LLC (the “Distributor”, “we” or “us”) will act as manager of registered at-the-market offerings by BlackRock Health Sciences Trust, a Delaware statutory trust (the “Fund”), of up to 2,500,000 common shares (the “Shares”) of beneficial interest, par value $0.001 per share, of the Fund (the “Common Shares”). In the case of such offerings, the Fund has agreed with the Distributor to issue and sell through or to the Distributor, as sales agent and/or principal, the Shares (the “Distribution Agreement”).
SECOND AMENDED AND RESTATED DISTRIBUTION AGREEMENTDistribution Agreement • April 27th, 2018 • BlackRock Health Sciences Trust • New York
This SECOND AMENDED AND RESTATED DISTRIBUTION AGREEMENT (the “Agreement”) made as of September 5, 2017 by and between BlackRock Health Sciences Trust, a Delaware statutory trust (the “Fund”), and BlackRock Investments, LLC, a Delaware limited liability company (the “Distributor”).
Closed-End Fund Master Advisory Fee Waiver AgreementMaster Advisory Fee Waiver Agreement • April 27th, 2018 • BlackRock Health Sciences Trust • New York
This MASTER ADVISORY FEE WAIVER AGREEMENT (this “Agreement”) is made as of the 2nd day of December, 2016, by and among BlackRock Advisors, LLC (the “Adviser”) an “Adviser”) and each investment company listed on Schedule A attached hereto (each, a “Fund”).
